<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="correction"><front><journal-meta><journal-id journal-id-type="nlm-ta">Breast Cancer (Dove Med Press)</journal-id><journal-id journal-id-type="iso-abbrev">Breast Cancer (Dove Med Press)</journal-id><journal-id journal-id-type="publisher-id">Breast Cancer: Targets and Therapy</journal-id><journal-title-group><journal-title>Breast Cancer : Targets and Therapy</journal-title></journal-title-group><issn pub-type="epub">1179-1314</issn><publisher><publisher-name>Dove Medical Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26170717</article-id><article-id pub-id-type="pmc">4489820</article-id><article-id pub-id-type="doi">10.2147/BCTT.S84920</article-id><article-id pub-id-type="publisher-id">bctt-7-163</article-id><article-categories><subj-group subj-group-type="heading"><subject>Corrigendum</subject></subj-group></article-categories><title-group><article-title>BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase [Corrigendum]</article-title></title-group><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>29</day><month>6</month><year>2015</year></pub-date><volume>7</volume><fpage>163</fpage><lpage>163</lpage><permissions><copyright-statement>© 2015 Larsen et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License</copyright-statement><copyright-year>2015</copyright-year><license><license-p>The full terms of the License are available at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.</license-p></license></permissions></article-meta></front><body><p><offsets xml_i="2180" xml_f="2227" txt_i="7" txt_f="54">Larsen S, Butthongkomvog K, Manikhas A, et al. </offsets><italic><offsets xml_i="2235" xml_f="2269" txt_i="54" txt_f="88">Breast Cancer: Targets and Therapy</offsets></italic><offsets xml_i="2278" xml_f="2287" txt_i="88" txt_f="97">. 2014;6:</offsets><related-article related-article-type="corrected-article" id="d35e58" vol="6" page="179" xlink:href="25473312" ext-link-type="pubmed"><offsets xml_i="2421" xml_f="2428" txt_i="97" txt_f="104">179–189</offsets></related-article><offsets xml_i="2446" xml_f="2447" txt_i="104" txt_f="105">.</offsets></p><p><offsets xml_i="2454" xml_f="2487" txt_i="106" txt_f="139">On page 184 there is an error in </offsets><xref ref-type="fig" rid="f1-bctt-7-163"><offsets xml_i="2528" xml_f="2537" txt_i="139" txt_f="148">Figure 3A</offsets></xref><offsets xml_i="2544" xml_f="2627" txt_i="148" txt_f="231">. The error consists of a yellow bar at +16 days in the placebo group. The correct </offsets><xref ref-type="fig" rid="f1-bctt-7-163"><offsets xml_i="2668" xml_f="2677" txt_i="231" txt_f="240">Figure 3A</offsets></xref><offsets xml_i="2684" xml_f="2698" txt_i="240" txt_f="254"> appears here:</offsets></p></body><floats-group><fig id="f1-bctt-7-163" position="float"><label>Figure 3A</label><graphic xlink:href="bctt-7-163Fig1"></graphic></fig></floats-group></article>